FR2199988B1 - - Google Patents

Info

Publication number
FR2199988B1
FR2199988B1 FR7333497A FR7333497A FR2199988B1 FR 2199988 B1 FR2199988 B1 FR 2199988B1 FR 7333497 A FR7333497 A FR 7333497A FR 7333497 A FR7333497 A FR 7333497A FR 2199988 B1 FR2199988 B1 FR 2199988B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7333497A
Other languages
French (fr)
Other versions
FR2199988A1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHRISTIAENS MANUF PROD PHARMA
Original Assignee
CHRISTIAENS MANUF PROD PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHRISTIAENS MANUF PROD PHARMA filed Critical CHRISTIAENS MANUF PROD PHARMA
Publication of FR2199988A1 publication Critical patent/FR2199988A1/fr
Application granted granted Critical
Publication of FR2199988B1 publication Critical patent/FR2199988B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FR7333497A 1972-09-18 1973-09-18 Expired FR2199988B1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998873 1973-03-01
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB1030373 1973-03-02

Publications (2)

Publication Number Publication Date
FR2199988A1 FR2199988A1 (de) 1974-04-19
FR2199988B1 true FR2199988B1 (de) 1977-11-25

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7333497A Expired FR2199988B1 (de) 1972-09-18 1973-09-18

Country Status (13)

Country Link
JP (1) JPS5327263B2 (de)
AR (4) AR206505A1 (de)
CA (1) CA992547A (de)
CH (1) CH585690A5 (de)
DD (2) DD109802A5 (de)
ES (3) ES418827A1 (de)
FR (1) FR2199988B1 (de)
GB (1) GB1405444A (de)
HU (1) HU168018B (de)
IL (1) IL43218A (de)
LU (1) LU68426A1 (de)
MX (1) MX3233E (de)
NL (1) NL152246B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (de) * 1989-01-09 1990-07-25
PT1185267E (pt) * 1999-06-10 2006-12-29 Bridge Pharma Inc Agentes anestesicos dermicos
EP1658847A3 (de) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indanderivate als dermale Anästhetika
EP1132093A4 (de) 1999-09-17 2006-04-19 Daiichi Suntory Pharma Co Ltd Vorbeugungsmittel oder heilmittel gegen myokarditis, dilatierte kardiomyopathie und herzinsuffiziens, die nf-kappa b inhibitoren als aktiven bestandteil enthalten
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain

Also Published As

Publication number Publication date
ES418827A1 (es) 1977-02-01
CA992547A (en) 1976-07-06
AR203500A1 (es) 1975-09-15
DD109802A5 (de) 1974-11-20
DE2346337B2 (de) 1976-08-26
ES440030A1 (es) 1977-02-16
NL152246B (nl) 1977-02-15
IL43218A0 (en) 1973-11-28
GB1405444A (en) 1975-09-10
NL7312776A (de) 1974-03-20
DD108277A5 (de) 1974-09-12
JPS5327263B2 (de) 1978-08-07
MX3233E (es) 1980-08-05
DE2346337A1 (de) 1974-04-04
AR204247A1 (es) 1975-12-10
AR206505A1 (es) 1976-07-30
CH585690A5 (de) 1977-03-15
FR2199988A1 (de) 1974-04-19
IL43218A (en) 1977-05-31
LU68426A1 (de) 1973-11-26
HU168018B (de) 1976-02-28
ES440029A1 (es) 1977-02-16
JPS4969648A (de) 1974-07-05
AR205891A1 (es) 1976-06-15
AU6028373A (en) 1975-03-13

Similar Documents

Publication Publication Date Title
FR2212820A5 (de)
JPS4954197A (de)
JPS4969648A (de)
JPS4944752A (de)
FR2174690B1 (de)
JPS4990727A (de)
FR2196493B1 (de)
JPS4927017A (de)
JPS4940196U (de)
JPS4947648U (de)
JPS4928652A (de)
JPS5142627Y2 (de)
JPS5113612Y2 (de)
JPS5212044Y2 (de)
JPS5128280B2 (de)
JPS4971536A (de)
JPS4989767U (de)
JPS4949906U (de)
JPS4957487A (de)
JPS4962326U (de)
CS156683B1 (de)
CH1658373A4 (de)
CH590289A5 (de)
CH1612672A4 (de)
CH576505A5 (de)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse